LENZ Therapeutics, Inc. (LENZ)
3.20
-0.30
(-8.57%)
USD |
NASDAQ |
Nov 18, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
LENZ Therapeutics Price : 3.20 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 3.82 | 3.85 | 3.43 | 3.50 | 775407.0 |
| Nov 16, 2026 | 4.10 | 4.14 | 3.78 | 3.82 | 1.028M |
| Nov 13, 2026 | 4.06 | 4.174 | 3.91 | 4.13 | 748621.0 |
| Nov 12, 2026 | 4.10 | 4.125 | 3.94 | 4.09 | 773093.0 |
| Nov 11, 2026 | 4.15 | 4.32 | 4.01 | 4.11 | 605912.0 |
| Nov 10, 2026 | 4.20 | 4.23 | 4.01 | 4.10 | 928431.0 |
| Nov 09, 2026 | 3.57 | 4.37 | 3.40 | 4.29 | 1.539M |
| Nov 06, 2026 | 3.00 | 3.51 | 3.00 | 3.50 | 785674.0 |
| Nov 05, 2026 | 3.44 | 3.44 | 3.00 | 3.01 | 737004.0 |
| Nov 04, 2026 | 3.60 | 3.70 | 3.36 | 3.46 | 1.236M |
| Nov 03, 2026 | 3.04 | 3.73 | 3.04 | 3.50 | 1.565M |
| Nov 02, 2026 | 3.07 | 3.19 | 2.80 | 3.05 | 2.258M |
| Oct 30, 2026 | 3.38 | 3.425 | 3.04 | 3.05 | 2.264M |
| Oct 29, 2026 | 3.00 | 3.58 | 2.995 | 3.49 | 5.987M |
| Oct 28, 2026 | 3.10 | 3.219 | 3.07 | 3.21 | 573899.0 |
| Oct 27, 2026 | 3.13 | 3.19 | 3.075 | 3.15 | 377751.0 |
| Oct 26, 2026 | 3.16 | 3.195 | 3.095 | 3.145 | 389145.0 |
| Oct 23, 2026 | 3.23 | 3.23 | 3.06 | 3.16 | 696455.0 |
| Oct 22, 2026 | 3.25 | 3.285 | 3.18 | 3.25 | 435473.0 |
| Oct 21, 2026 | 3.20 | 3.37 | 3.145 | 3.22 | 943347.0 |
| Oct 20, 2026 | 3.27 | 3.33 | 3.12 | 3.19 | 819366.0 |
| Oct 19, 2026 | 3.27 | 3.40 | 3.209 | 3.30 | 648751.0 |
| Oct 16, 2026 | 3.56 | 3.56 | 3.21 | 3.27 | 939082.0 |
| Oct 15, 2026 | 3.43 | 3.64 | 3.43 | 3.57 | 793846.0 |
| Oct 14, 2026 | 3.39 | 3.615 | 3.345 | 3.43 | 1.040M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| EyePoint, Inc. | 0.2706 |
| Ligand Pharmaceuticals, Inc. | 299.00 |
| Bristol Myers Squibb Co. | 59.57 |
| Context Therapeutics, Inc. | 0.1645 |
| Neumora Therapeutics, Inc. | 0.3624 |
Price Related Metrics
| PS Ratio | 8.105 |
| PEG Ratio | -0.0063 |
| Price to Book Value | 0.5237 |
| Earnings Yield | -140.0% |
| Market Cap | 100.55M |
| PEGY Ratio | -0.0063 |